Salivary Gland Carcinoma — Trials

Salivary Gland Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

186 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 52
Recruiting: 25
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 22.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (21)

clinicaltrialsPublishedShowing 51–53 of 53 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00096512	S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer	completed	Phase 2	40	National Cancer Institute (NCI)NIH	1	Feb 28, 2013	clinicaltrials
NCT00033618	Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck	completed	Phase 2	144	National Cancer Institute (NCI)NIH	1	Feb 27, 2013	clinicaltrials